Cedar Grove Capital Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...

One rising WWE star is rapidly being replacing Brock Lesnar as the company’s most explosive ever star in the minds of fans.

Eye care company Alcon Inc., which has a major presence in North Texas, plans to buy Lensar Inc. in a deal valued up to $430 million. Orlando-based Lensar (Nasdaq: LNSR) is a laser cataract ...

— We have everything you need: full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; ...

LENSAR has a 1 year low of $2.67 and a 1 year high of $17.31. Get LENSAR alerts: LENSAR (NASDAQ:LNSR – Get Free Report) last announced its quarterly earnings results on Thursday, February 27th.

Lake Street analyst Frank Takkinen downgraded Lensar (LNSR) to Hold from Buy with a price target of $15, down from $16, after Alcon (ALC) announced the acquisition of Lensar for $14.00 per share ...

Per the terms of the agreement, Alcon will purchase all outstanding shares of LENSAR for $14.00 per share in cash, with an additional non-tradeable contingent value right offering up to $2.75 per ...

Fintel reports that on March 24, 2025, Lake Street downgraded their outlook for LENSAR (NasdaqCM:LNSR) from Buy to Hold. Analyst Price Forecast Suggests 11.26% Upside As of March 19, 2025 ...

Alcon will buy Lensar’s outstanding shares for $14 per share. The deal is expected to close in the second half of 2025. Perspective from John A. Hovanesian, MD, FACS Alcon will expand its ...

--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and LENSAR, Inc. (NASDAQ: LNSR), a global medical technology company focused on ...